Pharmacoeconomics of haemophilia.
Pharmacoeconomic analysis is one method of providing health-care decision-makers with information to assist them in assigning priorities for the allocation of resources, both within a particular disease area and between different diseases. Conducted well, such analyses can provide a valuable contribution to the published literature which can contribute to improving clinical outcomes through the endorsement of evidence-based medicine. The treatment of haemophilia with replacement therapy is an area which could benefit from such an approach, both by modelling pharmacoeconomic analyses on published clinical studies and by incorporating pharmacoeconomic analysis and quality of life measurements alongside existing clinical trials.